Yamo Pharmaceuticals Receives Investment from Autism Impact Fund to Support Phase 2 Study of L1-79 in Autism Spectrum Disorder New York, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC, a clinical stage pharmaceutical company developing a novel therapy for the core symptoms of the autism spectrum disorder (ASD),...

Disability Care Platform Joshin Closes $3M Seed Round; Launches in Los Angeles and Seattle MINNEAPOLIS, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Joshin, a digital care platform that connects care providers to families with specialized care needs, announced today that it has closed a seed funding...